KPV (Lysine-Proline-Valine) — C-terminal alpha-MSH tripeptide research compound studied in inflammatory pathway and immune research.

KPV is a tripeptide research compound consisting of Lysine-Proline-Valine — the C-terminal sequence of alpha-MSH. Despite its small size, it has shown remarkable activity in research models.
KPV is studied for its effects on multiple inflammatory pathways including NF-κB modulation. Research has investigated both melanocortin-receptor-dependent and independent mechanisms.
Used in research on: inflammation pathways, gut research models, immune signaling, comparative MSH fragment studies, oral bioavailability research.
| Compound | KPV |
| Available Strengths | 5mg, 10mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.